1. Home
  2. BPYPN vs CSCI Comparison

BPYPN vs CSCI Comparison

Compare BPYPN & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPYPN
  • CSCI
  • Stock Information
  • Founded
  • BPYPN N/A
  • CSCI 1990
  • Country
  • BPYPN Bermuda
  • CSCI Canada
  • Employees
  • BPYPN 30200
  • CSCI N/A
  • Industry
  • BPYPN Real Estate
  • CSCI
  • Sector
  • BPYPN Finance
  • CSCI
  • Exchange
  • BPYPN Nasdaq
  • CSCI NYSE
  • Market Cap
  • BPYPN N/A
  • CSCI 9.9M
  • IPO Year
  • BPYPN N/A
  • CSCI 1996
  • Fundamental
  • Price
  • BPYPN $13.18
  • CSCI $3.38
  • Analyst Decision
  • BPYPN
  • CSCI
  • Analyst Count
  • BPYPN 0
  • CSCI 0
  • Target Price
  • BPYPN N/A
  • CSCI N/A
  • AVG Volume (30 Days)
  • BPYPN N/A
  • CSCI 3.5K
  • Earning Date
  • BPYPN N/A
  • CSCI 05-20-2025
  • Dividend Yield
  • BPYPN N/A
  • CSCI N/A
  • EPS Growth
  • BPYPN N/A
  • CSCI N/A
  • EPS
  • BPYPN N/A
  • CSCI N/A
  • Revenue
  • BPYPN N/A
  • CSCI $9,587,000.00
  • Revenue This Year
  • BPYPN N/A
  • CSCI N/A
  • Revenue Next Year
  • BPYPN N/A
  • CSCI N/A
  • P/E Ratio
  • BPYPN N/A
  • CSCI N/A
  • Revenue Growth
  • BPYPN N/A
  • CSCI 34.22
  • 52 Week Low
  • BPYPN N/A
  • CSCI $1.96
  • 52 Week High
  • BPYPN N/A
  • CSCI $11.10
  • Technical
  • Relative Strength Index (RSI)
  • BPYPN 58.42
  • CSCI N/A
  • Support Level
  • BPYPN $12.60
  • CSCI N/A
  • Resistance Level
  • BPYPN $13.00
  • CSCI N/A
  • Average True Range (ATR)
  • BPYPN 0.25
  • CSCI 0.00
  • MACD
  • BPYPN 0.10
  • CSCI 0.00
  • Stochastic Oscillator
  • BPYPN 75.97
  • CSCI 0.00

About BPYPN Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3

Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

About CSCI COSCIENS BIOPHARMA INC

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

Share on Social Networks: